Co Diagnostics (Germany) Top Insiders

Co Diagnostics Management Team Effectiveness

The company has return on total asset (ROA) of 48.56 % which means that it generated a profit of $48.56 on every $100 spent on assets. This is very large. Similarly, it shows a return on equity (ROE) of 76.64 %, meaning that it generated $76.64 on every $100 dollars invested by stockholders. Co Diagnostics' management efficiency ratios could be used to measure how well Co Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Co Diagnostics secures a total of 28.67 Million outstanding shares. Co Diagnostics owns 6.15 % of its outstanding shares held by insiders and 25.41 % owned by institutions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Co Diagnostics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Co Diagnostics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Co Diagnostics Workforce Comparison

The company has Profit Margin (PM) of 47.97 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 52.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $52.1.

Co Diagnostics Benchmark Summation

Co Diagnostics Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Co Diagnostics often depends on how effective the management is. Co Diagnostics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of C97 management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the C97 management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.